Navigation Links
Novel Technology in Treating Chronic Sinus Infections Available at Baptist
Date:11/25/2009

Thirty-seven million Americans are afflicted with sinusitis. A clinically proven, minimally invasive technology for treating chronic sinus inflammation is available at Baptist Medical Center in Jackson, Miss. The Balloon Sinuplasty™ system by Acclarent™ uses a small catheter and balloon to quickly open and expand blocked sinuses.

(Vocus) November 25, 2009 -- A clinically proven, minimally invasive technology for treating chronic sinus inflammation is available at Baptist Medical Center in Jackson, Miss. The Balloon Sinuplasty™ system by Acclarent™ uses a small catheter and balloon to quickly open and expand blocked sinuses.

Sinusitis is one of the most common chronic health problems in the U.S., afflicting 37 million Americans each year. Patients suffer headaches, congestion, fatigue and other symptoms. This condition significantly impacts an individual's physical, functional, and emotional quality of life.

Until recently, sinusitis patients were limited to two treatment options: medical therapy such as antibiotics and topical nasal steroids, or conventional sinus surgery such as Functional Endoscopic Sinus Surgery (FESS). Medical therapy can help alleviate symptoms for 75-80 percent of patients but is inadequate for the rest. For them, sinus surgery is often the best option. However, FESS is a conventional surgery that requires bone and tissue removal in order to open up blocked sinus passageways. In lieu of a desired treatment, more than 600,000 patients elect to live with painful sinus conditions.

Now, there is an evolution in endoscopic sinus surgery with the Balloon Sinuplasty™ technology by Acclarent™. A small, flexible balloon catheter is placed through a nostril into the blocked sinus passageway. The balloon is then inflated to gently restructure and open the sinus passageway, restoring normal sinus drainage and function.

Otolaryngologist William Sneed, MD, is one of the first physicians in this area to offer this technology. He says, "The Balloon Sinuplasty™ is a true advance in sinus care because in many cases it can be done without removing any tissue or bone. That means faster recovery times and less post-procedure discomfort. In fact, many of my patients have been able to return to normal activities within 24 hours and have had significant improvement in their symptoms."

The international, multi-center study call CLEAR stands for The CLinical Evaluation to Confirm SAfety and Efficacy of Sinuplasty in the PaRanasal Sinuses. It confirmed in the July 2007 issue of the prestigious journal, Otolaryngology-Head and Neck Surgery, earlier rigorous clinical validation that the Balloon Sinuplasty™ instruments by Acclarent™ are safe and effective for opening blocked sinuses. The CLEAR study reported 24-week results on 109 patients, which demonstrated:

 
  • 0% adverse event rate
  • 96.9% successful ostial dilation
  • 98% observed ostial patency rate
  • 81% overall patency rate (17% of ostia indeterminate due to anatomical preservation)
  • Clinically and statistically significant improvement in patient symptoms

Sinusitis patients who are considering their options can learn more about the Balloon Sinuplasty™ technology by Acclarent™ by contacting Baptist Health Line at 601-948-6262.

ABOUT BAPTIST HEALTH SYSTEMS
Baptist Health Systems is the parent company of Baptist Medical Center, The Mississippi Hospital for Restorative Care and a number of related healthcare services and programs. For over 100 years, Baptist Medical Center has served Mississippi and the surrounding states as a Christian-based, non-profit comprehensive medical Center.
From its beginnings in 1908, Baptist has grown to include a medical center providing comprehensive services for people in every stage of life. The 500+ members of Baptist’s medical staff represent more than 85 medical specialties.

Baptist Medical Center has been awarded the Gold Seal of Approval ™ and has achieved Disease-Specific Care Certification from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in the areas of cancer services, acute coronary syndrome and outpatient diabetes. Additionally, Baptist was the first organization in the United States to earn this distinction for an entire cancer program.
Visit Baptist on the web at www.mbhs.org. For more information contact the Baptist Health Line at 1-800-948-6262 or 948-6262.

Follow Baptist on Twitter at www.twitter.com/baptistmednews. Become a Baptist Facebook fan at www.facebook.com/baptistmednews. Or, view us on YouTube at www.youtube.com/baptistmednews.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3258154.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Novel K-anonymity algorithm safeguards access to data
2. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
3. Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
4. Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique
5. Porter Novelli Wins Gold from Medical Marketing & Media for Best Unbranded TV Ad
6. NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age-Related Macular Degeneration
7. Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation
8. Possible Novel H1N1 Cases in Pigs Not Unexpected; Experts Say U.S. Pork Is Safe to Eat
9. SRI International Awarded a Department of Defense Laboratory-Clinical Transition Grant to Advance SRIs Novel Anticancer Agents for Prostate Cancer Treatment
10. Novel Facebook Application Aims to Prevent Cervical Cancer
11. Toronto researchers discover novel circulation in human eye, new glaucoma treatment target
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel Technology in Treating Chronic Sinus Infections Available at Baptist
(Date:5/4/2016)... ... May 04, 2016 , ... The RIDER ... and development of DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective against all ... May 3, 2016 at http://igg.me/at/EndTheVirus and runs for 60 days, we ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nike Rugby Camp's success is due ... Diego. Willis, founder of Elite Rugby Camps and current Nike Camp director, has offered ... since 2009. , “I’m excited for our eighth summer here in San Diego,” ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... program created to assist the people of their local community. The agency pledges ... and community leaders. Their hope is to bring awareness to important local causes ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, dentist ... their office. Wisdom tooth removal, a common dental procedure, is performed for many adolescents ... improperly erupted, resulting in risks of complications. By providing wisdom tooth removal surgery at ...
(Date:5/4/2016)... NC (PRWEB) , ... May 04, 2016 , ... Francesca ... N.C., changed her life forever with a same-day LASIK procedure at Christenbury ... poor eyesight. Dr. Jonathan Christenbury performed her surgery the same day as her in-office ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute lymphocytic ... 2016"  report to their offering.  ... Global Acute Lymphocytic Leukemia Market and ... into Acute Lymphocytic Leukemia pipeline products, Acute ...
(Date:5/3/2016)... TUCSON, Ariz. , May 3, 2016  As ... twice contracted rheumatic fever, which damaged his heart. ... But by June 2013, Shepherd,s heart was ... days from death. On June 20, 2013, the ... temporary Total Artificial Heart (TAH-t). Like a heart transplant, ...
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology: